Assertio Therapeutics News and Activities

Assertio Therapeutics is owned by Zydus Group.

Zydus Group is one of the...

• Nifty 500;
• TOB Iconic 10,000.

Zydus Group is a company listed under the stock ticker ZYDUSLIFE (IN).

Zydus Group has a direct presence in 2 countries.

Zydus Group has 4 subsidiaries including Assertio Therapeutics, Zydus Healthcare and Zydus Medtech.

They are in:

• Pharmaceuticals40%
• Healthcare40%
• Other20%

Acquisition, funding and merger involving Zydus Group.

• Zydus Group has announced the acquisition of Assertio Therapeutics  (posted on May 19 2026).
• Garda Therapeutics has announced the acquisition of Assertio Therapeutics  (posted on May 8 2026).

View the org chart displaying its 18 main executives

Most searched biographies at Assertio Therapeutics

• Mark Reisenauer, Chief Executive Officer
• Punit Patel, Director
• Ravi Yadavar, Director

Popular executive movements at Assertio Therapeutics

• Ravi Yadavar has joined the company as Director  (posted on June 17 2026).
• David Stark, Director, has left the company  (posted on June 17 2026).
• Punit Patel has joined the company as Director  (posted on June 17 2026).

Click here to view some more movements at Assertio Therapeutics

Popular executive movements at Zydus Group

• Kulin Lalbhai has joined the company as Independent Director  (posted on May 21 2026).
• Apurva Diwanji, Director, has left the company  (posted on May 16 2026).
• Ajaykumar Sharma has joined the company as Senior Vice President & Head of Corporate Affairs  (posted on March 26 2026).

Click here to view some more movements at Zydus Group

Create your alert
to follow the executive moves at Assertio Therapeutics.

Zydus Group has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Novartis has announced the acquisition of Myricx Bio  (posted on July 6 2026).
• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Assertio Therapeutics

• Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027
• Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash
• Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
• Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer
• Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
• Assertio and Garda Mutually Agree to Extend Tender Offer Deadline
• Assertio Provides Update on Garda Therapeutics Tender Process
• Assertio Announces Agreement to be Acquired by Garda Therapeutics
• Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
• Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
• View more press releases Close

Social media about Assertio Therapeutics

• Assertio Therapeutics on Wikipedia, Google News & Yahoo Finance
• Assertio Therapeutics on LinkedIn, X (Twitter) & YouTube